Medicinal Product Containing The Active Substance Daratumumab 2025

Fakultni nemocnice Plzen Czech Republic has Released a tender for Medicinal Product Containing The Active Substance Daratumumab 2025 in Pharmaceuticals. The tender was released on Aug 20, 2025.

Country - Czech Republic

Summary - Medicinal Product Containing The Active Substance Daratumumab 2025

Deadline - Sep 22, 2025

MT reference number - 116003424

Product classification - Antineoplastic agents

Organization Details:

  Address - Czech Republic

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 116003424

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: The subject of the public contract is the supply of a medicinal product designed especially for the therapy of malignant plasma cell disease in the total expected volume of 3,000 individual doses (ampoules) of the medicinal product.The p roduct is intended for the provision of health care at medical workplaces of the University Hospital Pilsen. The supply of the subject of performance will be implemented on the basis of the results of the completed tender for three years from the signing of the purchase contract.Ampoules are a unit of form intended for injection or infusion administration - inj./inf. Bottle, crowded syringe, pre -filled pen, etc.The offered medicinal product must

Mt Ref Id - 116003424

Deadline - Sep 22, 2025

Share

Similar Tenders :